首页>投融资

ONL Therapeutics

D轮

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.In March 2023, ONL Therapeutics LLC closed on the first tranche of a $15 million Series C Preferred Stock financing round.In December 2020 ,ONL Therapeutics announced that it closed on $46.9 million in a Series B Preferred Stock financing round. In January 2022, ONL Therapeutics Inc closed on its second tranche of Series B financing raising $46.9 million.In August 2019, the company raised US $3 million in a convertible note financing.In May 2017, the company closed a US $4.25 million Series A round of fundraising

http://www.onltherapeutics.com/

470228

基本信息

公司全称

ONL Therapeutics Inc
类型

眼科药物研发商
产业领域

医药研发/制造、化学&生物药
公司人数

15~50人
地址

524 S. Main St,Suite 110 ANN ARBOR MICHIGAN 48104; US; Telephone: +17349988339;
联系电话

（734）998.8339
邮箱

info@onltherapeutics.com
成立时间

2011-01-01

投融资

2024-09-13

D轮

6500万美元

Johnson & Johnson Innovation

Visionary Venture Fund

Bios Partners

诺华
2023-03-08

C轮

1500万美元

Bios Partners

Visionary Venture Fund

Alpine Visionary

Mayewell Capital

Johnson & Johnson Innovation

凯泰资本

PSQ Capital

Michigan Capital

ExSight Ventures

Capital Community Angels

MINTS
2020-12-22

B轮

4690万美元

Capital Community Angels

Michigan Capital

MINTS

ExSight Ventures

InFocus Capital Partners

PSQ Capital

凯泰资本

强生（中国）

Bios Partners
2019-08-22

债权融资

300万美元

Invest Michigan

CCAI

InFocus Capital Partners

BRCC
2017-05-17

A轮

425万美元

诺华
2017-03-21

捐赠/众筹/授予

100万美元

National Institutes of Health
2014-11-12

捐赠/众筹/授予

137万美元

National Eye Institute
加载更多

ONL Therapeutics

基本信息

投融资

相关投融资企业